Dhanuka Agritech Performance
- Today's Low
- ₹1,058
- Today's High
- ₹1,065
- 52 Week Low
- ₹890
- 52 Week High
- ₹1,975
- Open Price₹1,062
- Previous Close₹1,051
- Volume1,394
- 50 DMA₹1,082.66
- 100 DMA₹1,102.96
- 200 DMA₹1,187.07
Dhanuka Agritech Chart
Investment Returns
- Over 1 Month -1.03%
- Over 3 Month + 8.96%
- Over 6 Month -12.25%
- Over 1 Year -37.36%
Smart Investing Starts Here Start SIP with Dhanuka Agritech for Steady Growth!
Dhanuka Agritech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -
- PEG Ratio
- -
- Market Cap Cr
- 4,797
- P/B Ratio
- 2.9
- Average True Range
- 37.81
- EPS
- 63.72
- Dividend Yield
- 0.2
- MACD Signal
- 10.19
- RSI
- 40.33
- MFI
- 64.2
Latest Stock News Updates
Agrochemicals company Dhanuka Agritech announced Q4FY26 & FY26 results Financial Highlights: Revenue from Operations for Q4FY26 was Rs 48,333.67 lakh, representing an increase of 17.91% QoQ from Rs 40,991.67 lakh in Q3FY26 and an increase of 9.35% YoY from Rs 44,202.32 lakh in Q4FY25. For the full year FY26, Revenue from Operations stood at Rs 2,01,978.96 lakh, a marginal decrease of 0.75% compared to Rs 2,03,515.18 lakh in FY25. Total Income for Q4FY26 was Rs 50,386.31 lakh, which grew by 20.53% QoQ from Rs 41,804.05 lakh in Q3FY26 and 11.18% YoY from Rs 45,317.88 lakh in Q4FY25. For the full year FY26, Total Income reached Rs 2,06,280.10 lakh compared to Rs 2,07,125.67 lakh in FY25. Net Profit for Q4FY26 reached Rs 9,777.06 lakh, showing a significant QoQ growth of 144.45% from Rs 3,999.54 lakh in Q3FY26 and a YoY growth of 29.49% from Rs 7,550.23 lakh in Q4FY25. For the full year FY26, the Net Profit stood at Rs 28,723.49 lakh, a decline of 3.27% from Rs 29,696.03 lakh in FY25. Basic and Diluted Earnings Per Share (EPS) for Q4FY26 stood at Rs 21.69, compared to Rs 8.87 in Q3FY26 and Rs 16.74 in Q4FY25. For the full year FY26, EPS was Rs 63.72 compared to Rs 65.55 in FY25. Business Highlights Equity Share Buyback: The Board approved a proposal to buy back up to 5,00,000 fully paid-up equity shares of face value Rs 2 each (representing 1.11% of the total paid-up equity capital) at a price of Rs 1,400 per share. The total offer size is up to Rs 70 crore. Dividend Recommendation: The Board of Directors has recommended a Final Dividend of 100% i.e., Rs 2 per equity share of face value Rs 2 for the financial year 2025-26. Employee Benefit Plans: The Board approved the introduction and adoption of the "Dhanuka Employee Stock Option Plan 2026" and the "Dhanuka Stock Appreciation Rights Plan, 2026," subject to shareholder approval. International Expansion: Approval was granted to set up wholly-owned subsidiaries or acquire shares in entities in Brazil and a European country to facilitate business growth. The initial investment limit for these entities is Rs 1 crore each. Management Changes: Mr. K.B. Kejariwal, Senior Management Personnel, retired from the services of the company effective from the close of business hours on March 31, 2026. Segment Performance: The company has only one reportable business segment, which is "Agro Chemicals". Result PDF
- Trendlyne
- 3 weeks 2 days ago
Agrochemicals company Dhanuka Agritech announced Q3FY26 results Revenues from Operations stood at Rs 409.92 crore in Q3FY26 vs Rs 445.27 crore in Q3FY25. EBITDA stood at Rs 58.66 crore in Q3FY26 vs Rs 75.56 crore in Q3FY25. Profit after tax was at Rs40.00 crore in Q3FY26 vs Rs 55.04 crore in Q3FY25. EPS: Rs 8.87 for Q3FY26. Chairman Message: Dhanuka Agritech is a leading Indian agrochemical company. Dhanuka is working with the vision of Transforming India through Agriculture. We have a Pan-India presence in all major states to reach out to more than 10 million farmers with our products and services. Dhanuka’s key focus has been on introduction of novel chemistries and extensive product development distinguishing us from the rest of the industry. With four manufacturing units and 41 warehouses across India, we cater to around 6,500 distributors and 80,000 retailers. Dhanuka has a strong Sales and Marketing team to promote and develop new products. Over last couple of years we have set up, 2 research and technology centers to enhance our focus on innovation and research. One of the centers is focused on applied chemistry and working for establishment of new products and new formulation development. The second laboratory is focused on innovation in process technology for generic and late stage patented products. To support our investments in innovation, we have significantly enhanced our regulatory team to speed up our Indian as well as International registration initiatives, providing us faster access to international markets and quicker introductions of new products. Dhanuka has international collaboration with ten leading global agrochemical companies from Japan, US and Europe, which helps us to introduce the latest technology in India. During this Quarter, Agrochemical demand remained weak due to stressed demand drivers (weather issues, low crop prices), leading to industry-wide volume decline. Farmer interest in purchasing high value products dropped due to lower crop and horticulture prices. South & West India saw sharp demand declines, while East & North remained stable. Indian farmers delayed purchases due to significantly extended rainfall and weaker commodity realizations. Lower farm incomes reduced spending on crop protection products, impacting domestic sales. Further, I am happy to share that we have commercialized the second product from Dahej plant in Q3FY26. We are working for making Dahej operations EBIDTA positive in FY27 and try to reach 80% capacity utilization of existing plant. Also, we are in the final stages of working for Business plan for MPP-2 and will be concluding the same within this year. I would like to assure our shareholders and other stakeholders that our strategy is well laid out, with continuous extension in rural market penetration, new product introductions, technical manufacturing and international market expansion. We are confident on delivering our longterm objective of achieving double digit CAGR. We consider ourselves responsible towards securing the farmer’s welfare and preserving food security of the nation. We continue to strengthen our association with the Agriculture Universities, Krishi Vigyan Kendras (KVKs) and other critical institutions to impart knowledge and latest technology to the Farmers. Result PDF
- Trendlyne
- 4 months ago
Agrochemicals company Dhanuka Agritech announced Q2FY26 results Revenues from Operations stood at Rs 598.25 crore in Q2FY26 vs Rs 654.28 crore in Q2FY25. EBITDA stood at Rs 136.73 crore in Q2FY26 vs Rs 159.58 crore in Q2FY25. Profit after tax was at Rs 93.97 crore in Q2FY26 vs Rs 117.52 crore in Q2FY25. Mahendra Kumar, Chairman, Dhanuka, said: "Dhanuka Agritech is a leading Indian agrochemical company. Dhanuka is working with the vision of Transforming India through Agriculture. We have a pan-India presence in all major states to reach out to more than 10 million farmers with our products and services. Dhanuka’s key focus has been on introduction of novel chemistries and extensive product development distinguishing us from the rest of the industry. With four manufacturing units and 41 warehouses across India, we cater to around 6,500 distributors and around 80,000 retailers. Dhanuka has a strong Sales and Marketing team to promote and develop new products. Dhanuka with 2 R&D; Laboratories has world-class NABL accredited laboratories as well as an excellent team for new product registration and development. Dhanuka has international collaboration with ten leading global agrochemical companies from Japan, US and Europe, which helps us to introduce the latest technology in India. During this Quarter, Abnormal and uneven rainfall distribution led to significant crop losses in various states. Some regions experienced excess rainfall, while others faced deficient showers, creating uneven soil moisture conditions. Crops in waterlogged areas suffered significant damage, reducing the application of agrochemicals. These conditions delayed harvesting and the application of crop protection product, limited pest infestation due to heavy rain washing off the pest, resulting in lower demand for agrochemical products from farmers. We are happy to inform you that we have received the Registration Certificate of Ipflufenoquin for indigenous manufacture u/s 9(3) duly approved by the Secretary, CIB&RC; for use in Transplanted Paddy for the control of Leaf blast & Neck blast. This product is introduced in collaboration with Nisso Chemicals, Japan. Further, I would like to share that we have started trial production of second product from our Dahej Plant. We Expect this product to help us increase the revenue from Dahej Plant. Also, our sales of Bifenthrin from Dahej is on track and in line with our annual objective. We consider ourselves responsible towards securing the farmer’s welfare and preserving food security of the nation. We continue to strengthen our association with the Agriculture Universities, Krishi Vigyan Kendras (KVKs) and other critical institutions to impart knowledge and latest technology to the Farmers." Result PDF
- Trendlyne
- 7 months 1 week ago
Dhanuka Agritech Financials
Dhanuka Agritech Technicals
EMA & SMA
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹1,096.00
- 50 Day
- ₹1,082.70
- 100 Day
- ₹1,103.00
- 200 Day
- ₹1,187.10
Resistance and Support
- R3 1,084.83
- R2 1,073.67
- R1 1,062.43
- S1 1,040.03
- S2 1,028.87
- S3 1,017.63
Dhanuka Agritech Corporate Actions - Bonus, Splits, Dividends
About Dhanuka Agritech
- NSE Symbol
- DHANUKA
- BSE Symbol
- 507717
- Managing Director
- Mr. Rahul Dhanuka
- ISIN
- INE435G01025
Similar Stocks to Dhanuka Agritech
Popular Stocks
Dhanuka Agritech FAQs
Dhanuka Agritech share price is ₹1,064 As on 12 June, 2026 | 09:26
The Market Cap of Dhanuka Agritech is ₹4796.8 Cr As on 12 June, 2026 | 09:26
The P/E ratio of Dhanuka Agritech is As on 12 June, 2026 | 09:26
The PB ratio of Dhanuka Agritech is 2.9 As on 12 June, 2026 | 09:26
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.